2019
DOI: 10.1001/jama.2019.8584
|View full text |Cite
|
Sign up to set email alerts
|

Hemoglobin A1c Levels During Pregnancy and Risk of Autism Spectrum Disorders in Offspring

Abstract: Maternal preexisting type 1, type 2, or gestational diabetes diagnosed relatively early in pregnancy are associated with increased risk for autism spectrum disorders (ASDs) in offspring. 1,2 This study extends previous observations by examining the association between maternal hemoglobin A 1c (HbA 1c) levels during pregnancy and risk of ASD in offspring.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
8
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
6

Relationship

2
4

Authors

Journals

citations
Cited by 9 publications
(8 citation statements)
references
References 3 publications
0
8
0
Order By: Relevance
“…Potential outliers and data errors were rectified by cross-checking against historical data in the EMR. Validation of the data was established in previous reports …”
Section: Methodsmentioning
confidence: 95%
See 2 more Smart Citations
“…Potential outliers and data errors were rectified by cross-checking against historical data in the EMR. Validation of the data was established in previous reports …”
Section: Methodsmentioning
confidence: 95%
“…A clinical diagnosis of ASD is based on pediatric developmental specialist evaluations. Methods to obtain the demographic characteristics, covariates, and ASD diagnoses in children have been described in previously published studies on the association between maternal diabetes during pregnancy and risk of ASD in children, which broadly represent the Southern California population . The KPSC Institutional Review Board approved this study and waived individual participant consent; as it was a data-only study, institutional safeguards to maintain risk were well detailed, including deidentification of patient information, the research involved minimal risk to participants, and the waiver would not adversely affect the rights and welfare of participants.…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…Therefore, antioxidative pathways, such as Nrf2/HO-1 discovered in this study, with active involvement in dyslipidemia and diabetes, are extremely likely to possess similar properties in preventing and treating GDM. Metformin and insulin are the two major drugs prescribed to treat GDM; however, the clinical practice of insulin is hindered by the inconvenient administration route as well as the potential to become hypoglycaemic and to gain weight (1,5,3). Our data demonstrated that H/R treatment markedly alleviated GDM symptoms via the activation of anti-oxidant enzymes (SOD, GPx and CAT) and restoration of the Nrf2/HO-1 signaling pathway.…”
Section: Discussionmentioning
confidence: 69%
“…GDM causes higher risks of diabetes, obesity and premature cardiovascular system disease during pregnancy for the fetus as well as the mother (3,2). GDM may also lead to deficits in fetal development, with ~15-45% of babies born by diabetic women exhibiting macrosomia symptoms (4,5).…”
Section: Introductionmentioning
confidence: 99%